Novel treatment options in rituximab-resistant membranous nephropathy patients
Novel treatment options in rituximab-resistant membranous nephropathy patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Novel treatment options in rituximab-resistant membranous nephropathy patients have?
Novel treatment options in rituximab-resistant membranous nephropathy patients has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Novel treatment options in rituximab-resistant membranous nephropathy patients published?
Novel treatment options in rituximab-resistant membranous nephropathy patients has 2022 year in the ScholarIQ index.
What is the open-access status of Novel treatment options in rituximab-resistant membranous nephropathy patients?
Novel treatment options in rituximab-resistant membranous nephropathy patients has closed oa status in the ScholarIQ index.
What is the DOI of Novel treatment options in rituximab-resistant membranous nephropathy patients?
The DOI for Novel treatment options in rituximab-resistant membranous nephropathy patients is on the source record.
What is the PMID of Novel treatment options in rituximab-resistant membranous nephropathy patients?
The PMID for Novel treatment options in rituximab-resistant membranous nephropathy patients is on the source record.
What is the OpenAlex record for Novel treatment options in rituximab-resistant membranous nephropathy patients?
The OpenAlex for Novel treatment options in rituximab-resistant membranous nephropathy patients is on the source record.